oligodendroglioma
Showing 26 - 50 of 387
Astrocytoma, Ependymoma, Ganglioglioma Trial in Maastricht, Delft, Groningen (ProTRAIT)
Recruiting
- Astrocytoma
- +11 more
- ProTRAIT
-
Maastricht, Limburg, Netherlands
- +2 more
Apr 12, 2022
CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)
Recruiting
- Central Nervous System Neoplasms
- +22 more
-
Bethesda, MarylandNational Institutes of Health
Mar 1, 2022
Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte
Active, not recruiting
- Recurrent Anaplastic Astrocytoma
- +6 more
- Carboxylesterase-expressing Allogeneic Neural Stem Cells
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 7, 2022
Glioma, Pilocytic Astrocytoma, Anaplastic Astrocytoma Trial in Saint Louis (MRI-guided laser ablation, Doxorubicin, Etoposide)
Recruiting
- Glioma
- +8 more
- MRI-guided laser ablation
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 22, 2022
Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Rochester (procedure,
Active, not recruiting
- Adult Anaplastic Astrocytoma
- +15 more
- biopsy
- +7 more
-
Rochester, MinnesotaMayo Clinic
Apr 8, 2022
Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients
Recruiting
- Medulloblastoma
- +7 more
- SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
- +2 more
-
Buffalo, New York
- +2 more
Jul 8, 2022
Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, Mixed Glioma Trial in Minneapolis, Portland (Carboplatin, Etoposide,
Completed
- Anaplastic Oligoastrocytoma
- +3 more
- Carboplatin
- +7 more
-
Minneapolis, Minnesota
- +1 more
Mar 11, 2022
Oligodendroglioma, Low-grade Oligodendroglioma, 1p19q Codeletion Trial in France (PCV chemo, Radiotherapy and PCV chemo)
Recruiting
- Oligodendroglioma
- +2 more
- PCV chemotherapy
- Radiotherapy and PCV chemotherapy
-
Amiens, France
- +25 more
Jun 14, 2022
Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma Trial in Worldwide (dabrafenib, trametinib)
Recruiting
- Diffuse Astrocytoma
- +22 more
-
Phoenix, Arizona
- +26 more
Jan 27, 2023
Proteomic Characterization of Aggressive Oligodendrogliomas
Recruiting
- Oligodendroglioma
- Proteomic analysis
-
Bron, France
- +1 more
Apr 12, 2021
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma Trial in New York (other, drug,
Completed
- Adult Anaplastic Astrocytoma
- +8 more
- Laboratory Biomarker Analysis
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 28, 2021
Oligodendroglioma Trial in Germany (CETEG, PCV, RT)
Recruiting
- Oligodendroglioma
- CETEG
- +2 more
-
Heidelberg, Baden-Württemberg, Germany
- +18 more
Sep 22, 2022
Anaplastic Oligodendroglioma, Oligoastrocytoma, Oligodendroglioma Trial in Los Angeles (Wear novoTTF-200A, Quality-of-Life
Withdrawn
- Anaplastic Oligodendroglioma
- +2 more
- Wear novoTTF-200A
- Quality-of-Life Assessment
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Dec 8, 2020
Clinical Development of Cancer-Specific MRS Biomarkers in
Completed
- Malignant Gliomas
- +2 more
- 3 Tesla scanning
-
Dallas, TexasUT Southwestern Medical Center
Jan 19, 2022
Educating Brain Tumor Patients Using Patient-specific
Recruiting
- Brain Tumor
- +7 more
- Three-dimensional printed model
-
Nijmegen, Gelderland, NetherlandsRadboud University Medical Center
Jul 10, 2021
Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)
Active, not recruiting
- Anaplastic Astrocytoma
- +6 more
- Laboratory Biomarker Analysis
- +4 more
-
Los Angeles, California
- +11 more
Jul 1, 2022
MicroRNA-10b in Patients With Gliomas
Recruiting
- Astrocytoma
- +8 more
-
Boston, Massachusetts
- +3 more
May 30, 2021
Clinical Development of MR Spectroscopy and Imaging in Brain
Completed
- Malignant Gliomas
- +2 more
- 3 Tesla Scanning
- 7 Tesla Scanning
-
Dallas, TexasUT Southwestern Medical Center
Jan 19, 2022
Qualitative, Qualitative, and Functional Studies Over First Year
Completed
- Astrocytoma
- +2 more
- Hepatitis A Vaccine
- +3 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Oct 28, 2021
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma Trial in Duarte (biological,
Completed
- Adult Anaplastic Astrocytoma
- +6 more
- E. coli CD-expressing genetically modified neural stem cells
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 28, 2021
Grade II Glioma, Grade III Glioma, Grade IV Glioma Trial in Boston (Microdevice)
Recruiting
- Grade II Glioma
- +7 more
- Microdevice
-
Boston, MassachusettsBrigham and Women's Hospital
Feb 22, 2021
Oligodendroglioma; Oligoastrocytoma Trial in Marseille (Bis-Chloroethyl-Nitroso-Urea (BCNU) withTemozolomide)
Completed
- Oligodendroglioma; Oligoastrocytoma
- Bis-Chloroethyl-Nitroso-Urea (BCNU) withTemozolomide
-
Marseille, FranceAssistance Publique - Hôpitaux de Marseille
Feb 11, 2021
Low Grade Glioma, World Health Organization (WHO) Grade II Astrocytomas, Oligodendrogliomas Trial in San Francisco (Everolimus,
Terminated
- Low Grade Glioma
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Nov 3, 2021
Oligoastrocytoma, Astrocytoma, Oligodendroglioma Trial (device, procedure, other)
Completed
- Oligoastrocytoma
- +2 more
- fMRI
- +2 more
- (no location specified)
Sep 1, 2020